e-learning
resources
Munich 2006
Monday 04.09.2006
Burden of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Post-bronchodilator spirometry reduces COPD diagnosis rate by 30%
M. Bednarek, J. Maciejewski, R. Plywaczewski, D. Gorecka, J. Zielinski (Warsaw, Sierpc, Poland)
Source:
Annual Congress 2006 - Burden of COPD
Session:
Burden of COPD
Session type:
Thematic Poster Session
Number:
2620
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bednarek, J. Maciejewski, R. Plywaczewski, D. Gorecka, J. Zielinski (Warsaw, Sierpc, Poland). Post-bronchodilator spirometry reduces COPD diagnosis rate by 30%. Eur Respir J 2006; 28: Suppl. 50, 2620
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Lung function testing in the elderly – can we still use FEV1/FVC < 70% as a criterion of COPD?
Source: Eur Respir J 2006; 28: Suppl. 50, 613s
Year: 2006
Forcede expiratory volume in six second in the spirometric diagnosis of COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Spirometry in old age: feasibility and interpretation
Source: Eur Respir Mon; 2009: 43: 25–34
Year: 2009
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007
The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002
FEV
6
as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up
Source: Eur Respir J 2016; 47: 742-750
Year: 2016
Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR®
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Changes in spirometry (FVC and FEV
1
) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept